Pulmonary Arterial Hypertension: all 773 studies
Page 6 of 8. Open to participants first (142), then studies with results posted, then the rest; newest registration first within each.
- Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary HypertensionActive, not recruitingNCT03550729Not applicable
- Right Ventricular Pulmonary Vascular Interaction in Pulmonary HypertensionCompletedNCT03523910Not applicable
- Subcutaneous Elafin in Healthy SubjectsCompletedNCT03522935Phase 1
- Effect of BIA 5 1058 on Cardiac RepolarizationCompletedNCT03489005Phase 1
- Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension.Status unknownNCT03476629Not applicable
- Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal VolunteersCompletedNCT03464864Phase 1
- PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)TerminatedNCT03449524Phase 2
- A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.CompletedNCT03422328Phase 3
- Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial HypertensionStatus unknownNCT03401476Phase 2
- Epidemiology and Pathophysiological Mechanisms of HTAP in SS and SC Children in Martinique and Guadeloupe.CompletedNCT03368261Not applicable
- Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial HypertensionCompletedNCT03365479Not applicable
- Revatio Special Investigation for Long-term Use in Pediatric PatientsCompletedNCT03364244
- (RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment)CompletedNCT03362047Phase 2
- Spironolactone Therapy in Chronic Stable Right HF TrialCompletedNCT03344159Phase 4
- A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAHCompletedNCT03315507Phase 1
- Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) SubjectsCompletedNCT03304548
- Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial HypertensionCompletedNCT03293407
- Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)Active, not recruitingNCT03288025Not applicable
- Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial HypertensionCompletedNCT03282266Not applicable
- A Registry for Patients Taking UptraviCompletedNCT03278002
- Olaparib for PAH: a Pilot StudyTerminatedNCT03251872Early Phase 1
- Goal Oriented Strategy to Preserve Ejection Fraction TrialStatus unknownNCT03236818Phase 4
- The PAH Disability and Bothersomeness QuestionnaireStatus unknownNCT03235401
- Determinants of Right Heart Remodeling in Patients With CTEPH or PAHStatus unknownNCT03205085Not applicable
- Retrospective Data Analysis of Data From the Zurich PH RegistryCompletedNCT03198910
- Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United StatesCompletedNCT03197688
- Assessment of Blood Coagulation Disorders in Patients With Pulmonary HypertensionStatus unknownNCT03195543
- Pulmonary Artery Involvement in Takayasu's ArteritisCompletedNCT03189602
- Angiogenic Imaging in Pulmonary Arterial HypertensionCompletedNCT03166306Phase 1/2
- ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApyCompletedNCT03145298Phase 1
- Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial HypertensionWithdrawnNCT03139084
- Repeatability of OCT and IV-US in Pulmonary Arterial HypertensionCompletedNCT03105934Not applicable
- Inspiratory Muscle Training in Pulmonary HypertensionCompletedNCT03102294Not applicable
- Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial HypertensionCompletedNCT03057028Phase 1
- To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT03053739Phase 4
- The Effects of Commercial Air Travel on Patients Suffering From Pulmonary HypertensionStatus unknownNCT03051763
- Stress Echo 2020 - The International Stress Echo StudyStatus unknownNCT03049995
- Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.Status unknownNCT03045666Not applicable
- ADAPT - A Patient Registry of the Real-world Use of Orenitram®Active, not recruitingNCT03045029
- Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAHWithdrawnNCT03016468Phase 2
- Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial HypertensionWithdrawnNCT02999906Phase 3
- Pulmonary Vascular Disease Phenomics Program PVDOMICSActive, not recruitingNCT02980887
- Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)TerminatedNCT02968901Phase 4
- The Effect of Adding Exercise Training to Optimal Therapy in PAHCompletedNCT02961023Not applicable
- Physiopathology of Pulmonary Arterial Hypertension: Mechanistic StudiesStatus unknownNCT02959723
- FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With AmbrisentanWithdrawnNCT02958358Not applicable
- [18F]FES PET/CT in PAHTerminatedNCT02899533
- Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial HypertensionWithdrawnNCT02893995Phase 4
- LenusPro Pump in PAH Treated With TreprostinilStatus unknownNCT02889315
- Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial HypertensionCompletedNCT02885155
- An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial HypertensionWithdrawnNCT02882126Phase 4
- The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation PatientsCompletedNCT02859194Not applicable
- MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial HypertensionCompletedNCT02858791
- Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)CompletedNCT02845518Not applicable
- TReatment Of Pulmonary HYpertension 1-US StudyActive, not recruitingNCT02835950Not applicable
- Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)CompletedNCT02826252
- Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)CompletedNCT02825160
- Bleeding Frequency Under Anticoagulant Treatment in Pulmonary HypertensionCompletedNCT02800941
- 3D Imaging: Prognostic Role in Pulmonary Arterial HypertensionCompletedNCT02799979
- HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSIONCompletedNCT02799771
- Acute Effects of Benzbromaron on the Pulmonary CirculationCompletedNCT02790450Phase 2
- Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial HypertensionWithdrawnNCT02782052Phase 3
- Exhaled Breath Olfactory Signature of Pulmonary Arterial HypertensionCompletedNCT02782026Not applicable
- Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian PatientsStatus unknownNCT02768259
- Right Ventricular Metabolism in Pulmonary Arterial HypertensionCompletedNCT02763735
- Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585CompletedNCT02746237Phase 1
- A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary HypertensionWithdrawnNCT02684786Phase 1
- A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial HypertensionCompletedNCT02676947Phase 2
- Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAHStatus unknownNCT02652429Phase 3
- Dysregulation of Lipid Metabolism and Right Ventricular Function in PAHCompletedNCT02631421
- Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP TreatmentTerminatedNCT02583906Not applicable
- Cardiac Function and Exercise Capacity in Pulmonary Arterial HypertensionCompletedNCT02579954Not applicable
- Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)CompletedNCT02576002
- Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term OutcomeCompletedNCT02565030
- Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt LesionsCompletedNCT02552485
- A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical PracticeCompletedNCT02545465
- Pulmonary Artery Denervation for Treatment of Pulmonary Arterial HypertensionTerminatedNCT02525926Not applicable
- TReatment Of Pulmonary HYpertension 1 StudyStatus unknownNCT02516722Not applicable
- Study to Assess Acute Vasodilation Response of Inhaled Nitric OxideWithdrawnNCT02436512Phase 3
- Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)CompletedNCT02428985
- Ventricular Reversed Remodeling After LTX in PAH PatientsCompletedNCT02391441
- Aerobic Exercise Training in Pulmonary Arterial HypertensionCompletedNCT02371733Not applicable
- Evaluating Pulmonary Arterial Hypertension in Patients With Systemic SclerosisWithdrawnNCT02339961Not applicable
- Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)CompletedNCT02318186
- Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial HypertensionWithdrawnNCT02309463
- Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAHCompletedNCT02304198Phase 2/3
- A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAHTerminatedNCT02284737Phase 4
- The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHDCompletedNCT02267200
- Observatory of Pulmonary Arterial Hypertension of Congenital Heart DiseaseCompletedNCT02260362
- Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by UltrasoundTerminatedNCT02243111Not applicable
- Development of a New Tool for Dyspnea Measurement in Chronic Respiratory DiseasesCompletedNCT02229994
- Safety of Terbogrel in Patients With Primary Pulmonary HypertensionTerminatedNCT02223494Phase 2
- Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary HypertensionCompletedNCT02223481Phase 2
- 3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAHStatus unknownNCT02207868
- Imaging Control Study, 3D Echo, MR and RHC.Status unknownNCT02198456
- Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial HypertensionTerminatedNCT02169752Not applicable
- Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac ShuntWithdrawnNCT02138708Not applicable
- OPsumit USers RegistryCompletedNCT02126943
- Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAHCompletedNCT02112487Phase 3
- Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial HypertensionWithdrawnNCT02108743Phase 2